北美癌症治疗市场-增长、趋势和预测 (2022 - 2027)

北美癌症治疗市场按治疗类型、癌症类型(血癌、乳腺癌、前列腺癌、皮肤癌、呼吸道/肺癌)、最终用户和地理进行细分。

市场快照

Market Snapshot1
Study Period: 2017-2025
Base Year: 2021
CAGR: 8.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计北美癌症治疗市场在预测期内将以 8.1% 的复合年增长率增长。推动市场增长的某些因素包括癌症患病率的上升、主要参与者的强大研发举措以及政府提高癌症意识的举措。

2020 年 1 月,全球癌症项目与来自 Instituto Nacional Cancerologia (INCan)、Instituto Nacional de Salud Pública (INSP) 和 Instituto Nacional de Medicina Genómica (INMEGEN) 的合作伙伴主办了 UCSF-Mexico 癌症合作年会。UCSF-Mexico Cancer Initiative 旨在加强区域癌症研究能力并扩大墨西哥合作伙伴的机构癌症研究组合和培训活动。

根据加拿大癌症协会 (CCS) 2020 年的估计,到 2020 年底,加拿大可能会出现 225,800 例新的癌症病例和 83,300 例癌症死亡病例。平均而言,预计每天有 617 名加拿大人被诊断出患有癌症. 因此,由于上述因素,预计在预测期内将显示市场增长。

Scope of the report

As per the scope of the report, cancer therapies are drugs that block the growth and proliferation of cancer, by interfering with specific molecules, such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. These therapies include surgery, radiation therapy, chemotherapy, immunotherapy, etc. The North America Cancer Therapy Market is segmented by therapy type, cancer type, end user, and geography.

Report scope can be customized per your requirements. Click here.

主要市场趋势

目标治疗部分预计将在预测期内显示出最快的增长

靶向治疗是一种使用药物靶向参与癌细胞生长和存活的特定基因和蛋白质的治疗方法。它可以影响帮助癌症生长和存活的组织环境,或者它可以靶向与癌症生长相关的细胞,如血管细胞。

一些最常见的靶向治疗类型是单克隆抗体或小分子药物。此外,靶向治疗是癌症研究中一个快速发展的领域,研究人员正在通过临床试验研究许多新的靶点和药物。

据美国癌​​症协会估计,2018年美国新确诊癌症病例1,735,350例,因癌症死亡609,640例。美国最常见的癌症是乳腺癌、肺癌、前列腺癌、结直肠癌癌症、膀胱癌和皮肤癌。因此,不断增长的癌症病例以及与靶向治疗相关的研究不断增加,预计将在未来几年推动市场增长。

NA cancer therapy key trend 1.png

竞争格局

北美癌症治疗市场得到巩固。就市场份额而言,目前很少有主要参与者主导市场。安进公司、阿斯利康公司、拜耳公司、百时美施贵宝公司和强生公司等公司在癌症治疗市场占有重要份额。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Cancer

      2. 4.2.2 Strong R&D Initiatives from Key Players

      3. 4.2.3 Growing Government Initiatives for Cancer Awareness

    3. 4.3 Market Restraints

      1. 4.3.1 Fluctuation in Reimbursement Policies

      2. 4.3.2 High Cost of Cancer Therapies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Treatment Type

      1. 5.1.1 Chemotherapy

      2. 5.1.2 Targeted Therapy

      3. 5.1.3 Immunotherapy

      4. 5.1.4 Hormonal Therapy

      5. 5.1.5 Other Treatment Types

    2. 5.2 By Cancer Type

      1. 5.2.1 Blood Cancer

      2. 5.2.2 Breast Cancer

      3. 5.2.3 Prostate Cancer

      4. 5.2.4 Gastrointestinal Cancer

      5. 5.2.5 Gynecologic Cancer

      6. 5.2.6 Respiratory/Lung Cancer

      7. 5.2.7 Other Cancer Types

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Spcialty Clinics

      3. 5.3.3 Cancer and Radiation Therapy Centers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Johnson and Johnson

      2. 6.1.2 AstraZeneca PLC

      3. 6.1.3 Merck & Co. Inc.

      4. 6.1.4 Bayer AG

      5. 6.1.5 Amgen Inc

      6. 6.1.6 F. Hoffmann-La Roche Ltd

      7. 6.1.7 Eli Lilly and Company

      8. 6.1.8 Novartis AG

      9. 6.1.9 Pfizer Inc

      10. 6.1.10 Bristol Myers Squibb Company

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Cancer Therapy Market market is studied from 2017 - 2025.

The North America Cancer Therapy Market is growing at a CAGR of 8.1% over the next 5 years.

Johnson and Johnson, AstraZeneca PLC, Merck & Co. Inc., Bayer AG, Amgen Inc are the major companies operating in North America Cancer Therapy Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!